Literature DB >> 28639207

The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).

M Rossi1, A R Taddei2, I Fasciani3, R Maggio4, F Giorgi5.   

Abstract

OBJECTIVE: Dichlorodiphenyltrichloroethane (DDT) is an organochlorine known for its pesticide properties and for its negative effects on human health. It was banned in most countries for its toxicity to the endocrine system, but due to its persistence at clinically relevant concentrations in both soil and animal tissues, DDT is still linked to several health and social problems.
METHODS: We have previously shown that DDT exposure is causally related to the extracellular release of vesicular organelles such as microvesicles and/or exosomes by using immunocytochemistry with gold-tagged antibodies and various fluorescent membrane markers.
RESULTS: It is now well recognized that microvesicles and/or exosomes organelles are implicated in cell-to-cell communication, and that they are fundamental elements for transferring proteins, RNA, DNA, lipids and transcriptional factors among cells. In this short review, we discussed the role of extracellular vesicle formation in the thyroid-disrupting mechanism of DDT. In particular, we described how DDT, by dislodging the thyrotropin hormone (TSH) receptor from the raft containing compartments of the cells, prevents its activation and internalization.
CONCLUSION: Based on our earlier finding and on the large body of evidence here reviewed, we propose that DDT-induced formation of extracellular vesicles containing the TSH receptor could be directly involved in the development of autoimmune responses against the TSH receptor and that, therefore, their release could lead to the development of the Graves' disease.

Entities:  

Keywords:  Dichlorodiphenyltrichloroethane; Extracellular vesicle; Graves’ disease; TSH receptor

Mesh:

Substances:

Year:  2017        PMID: 28639207     DOI: 10.1007/s40618-017-0716-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  49 in total

1.  Binding, uptake, and degradation of internalized thyroglobulin in cultured thyroid and non-thyroid cells.

Authors:  R Botta; S Lisi; A Pinchera; A R Taddei; A M Fausto; F Giorgi; M Marinò
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

Review 2.  Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function.

Authors:  Marco Scarselli; Paolo Annibale; Peter J McCormick; Shivakumar Kolachalam; Stefano Aringhieri; Aleksandra Radenovic; Giovanni U Corsini; Roberto Maggio
Journal:  FEBS J       Date:  2015-11-28       Impact factor: 5.542

3.  A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.

Authors:  Carsten Hoffmann; Guido Gaietta; Moritz Bünemann; Stephen R Adams; Silke Oberdorff-Maass; Björn Behr; Jean-Pierre Vilardaga; Roger Y Tsien; Mark H Ellisman; Martin J Lohse
Journal:  Nat Methods       Date:  2005-02-17       Impact factor: 28.547

Review 4.  Update in TSH receptor agonists and antagonists.

Authors:  Marvin C Gershengorn; Susanne Neumann
Journal:  J Clin Endocrinol Metab       Date:  2012-09-27       Impact factor: 5.958

Review 5.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

6.  Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome.

Authors:  Surya P Singh; David McDonald; Thomas J Hope; Bellur S Prabhakar
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

7.  Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway.

Authors:  S Lisi; R Botta; G Rotondo Dottore; M Leo; F Latrofa; P Vitti; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-04-19       Impact factor: 4.256

Review 8.  Recent advances of exosomes in immune modulation and autoimmune diseases.

Authors:  Lina Tan; Haijing Wu; Ying Liu; Ming Zhao; Duo Li; Qianjin Lu
Journal:  Autoimmunity       Date:  2016-06-03       Impact factor: 2.815

9.  Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.

Authors:  Syreeta L Tilghman; Melyssa R Bratton; H Chris Segar; Elizabeth C Martin; Lyndsay V Rhodes; Meng Li; John A McLachlan; Thomas E Wiese; Kenneth P Nephew; Matthew E Burow
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 10.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

View more
  5 in total

1.  Effect of Graves' disease on the prognosis of differentiated thyroid carcinoma: a meta-analysis.

Authors:  Yang Song; Lijun Fu; Pu Wang; Ning Sun; Xinguang Qiu; Jianhua Li; Shouhua Zheng; Shuwei Ren; Xiaochong Ding; Liwen Li; Junwei Du; Chenyi Wang; Zan Jiao; Wending Zhao
Journal:  Endocrine       Date:  2019-10-21       Impact factor: 3.633

Review 2.  Thyroid-disrupting chemicals and brain development: an update.

Authors:  Bilal B Mughal; Jean-Baptiste Fini; Barbara A Demeneix
Journal:  Endocr Connect       Date:  2018-03-23       Impact factor: 3.335

Review 3.  Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data.

Authors:  Michelle Leemans; Stephan Couderq; Barbara Demeneix; Jean-Baptiste Fini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-09       Impact factor: 5.555

Review 4.  The Roles of Exosomes in Immunoregulation and Autoimmune Thyroid Diseases.

Authors:  Junli Zou; Huiyong Peng; Yingzhao Liu
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 5.  Exosomes as Mediators of Cell-to-Cell Communication in Thyroid Disease.

Authors:  Yi Wang; Feng Xu; Jia-Yu Zhong; Xiao Lin; Su-Kang Shan; Bei Guo; Ming-Hui Zheng; Ling-Qing Yuan
Journal:  Int J Endocrinol       Date:  2020-04-28       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.